Pharmaceutical Formulation Intermediates

Showing 37–43 of 43 results

Tacrolimus Nano Solution

Tacrolimus is a potent immune suppressant. Tacrolimus is the first of the LIMUS based immunosuppressant to be marketed as a solid dosage capsule, infusion and ointment.
Murli Krishna Pharma’s technology addresses all the three formulations of Tacrolimus.
We do offer development services in case of a requirement for different formulation/dosage/strength
Offer complete technical package for registrations in all regulated/semi regulated markets
Products protected by ongoing Patents are not offered by MKPPL.

Release pattern compared with innovator Flomax.
MKPPL objective is to develop Tamsulosin hydrochloride SR pellets by aqueous phase and pellets developed by aqueous technology had better advantage of avoiding the use of organic solvents.
In case of fluid bed coater, to achieve the desired sustained release profile equivalent to innovator, MKPPL drug loaded pellets will be coated with polymers, either single polymer or in combination with different ratios.
In case of extrusion Spheronization, Tamsulosin hydrochloride SR pellets can be develop by preparing wet mass of API & Excipients.
Offer complete technical package for registrations in all regulated/semi regulated markets.

MKPPL has developed venlafaxine pellets equivalent to innovator product Effexor-XR using aqueous technology.
Venlafaxine pellets were formulated using the technique of extrusion and Spheronization. Extrusion eliminates dust during formulation and yields high quality pellets.
Sustain release polymer coating is applied to control the release of drug for extended period of time.
The dissolution is performed up to 20 hrs. with intermittent intervals as per USP monograph.
Offer complete technical package for registrations in all regulated/semi regulated markets.